ABT Abbott Laboratories

  • Official Name: ABBOTT LABORATORIES
  • Headquarters: 100 Abbott Park Road, Abbot Park, ABBOTT PARK, IL, 60064-3500 US
  • CEO: Robert B. Ford
  • Website: abbott.com
  • Key Investor: VANGUARD GROUP INC | 9.76%
  • Dedicated Investor: LIVELSBERGER FINANCIAL ADVISORY | 18.05%

Match Results

Date League Week Opponent Result Score
2025-07-18 1 Won by 4.187 (0.439) - (4.626)
2025-07-25 2 Won by 0.183 5.124 - 4.941
2025-07-29 2R Won by 1.756 1.374 - (0.382)
2025-08-01 3 Won by 1.605 1.056 - (0.549)
2025-08-07 1R Won by 0.808 0.706 - (0.102)
2025-08-08 4 Won by 0.106 TOTW 5.190 - 5.084
2025-08-12 3R Lost by 3.119 (0.449) - 2.670
2025-08-15 5 Won by 0.716 (0.486) - (1.202)
2025-08-20 1R Lost by 0.942 0.688 - 1.630
2025-08-21 2R Won by 0.277 (0.992) - (1.269)
2025-08-22 6 Won by 4.274 3.923 - (0.351)
2025-08-29 7 Lost by 1.060 0.051 - 1.111
2025-09-04 3R Won by 4.179 0.480 - (3.699)
2025-09-05 8 Won by 1.554 0.255 - (1.299)
2025-09-11 4R Won by 0.595 2.494 - 1.899
2025-09-12 9 Lost by 0.672 0.597 - 1.269
2025-09-18 5R Lost by 1.566 0.329 - 1.895
2025-09-19 10 Lost by 0.067 1.743 - 1.810
2025-09-26 11 Lost by 3.738 (1.807) - 1.931
2025-10-03 12 Lost by 1.946 0.718 - 2.664
2025-10-10 13 Lost by 3.879 (1.471) - 2.408
2025-10-17 14 Lost by 3.493 (2.675) - 0.818
2025-10-24 15 Lost by 1.242 (1.279) - (0.037)

Latest News

How Big Could BSX Stock's Next Fall Be?
Yahoo - 2026-09-28

How Big Could BSX Stock's Next Fall Be? 🔗

Boston Scientific (BSX) stock has lost more than half its value over the past 12 months, while the S&P 500 returned 18.0%. A subsequent setback oc...

Global Remote Cardiac Monitoring Market Size, Share & Trends Analysis 2026-2036 Featuring Profiles of Medtronic, Abbott Labs, Boston Scientific, GE HealthCare Technologies, Philips, Baxter International (Hillrom) and Other Key Players
Yahoo - 2026-09-28

Global Remote Cardiac Monitoring Market Size, Share & Trends Analysis 2026-2036 Featuring Profiles of Medtronic, Abbott Labs, Boston Scientific, GE HealthCare Technologies, Philips, Baxter International (Hillrom) and Other Key Players 🔗

Growth is driven by rising cardiovascular disease, telehealth adoption, and advances in wearable ECG devices, implantable monitors, AI analytics, and ...

Best Dividend Aristocrats For October 2026
SeekingAlpha - 2026-09-27

Best Dividend Aristocrats For October 2026 🔗

The ProShares S&P 500 Dividend Aristocrats ETF trails SPY YTD, but 20 individual Aristocrats are outperforming the ETF. Check out the Aristocrats ...

Gilead vs. Abbott: Which Dividend Healthcare Stock Offers the Better Risk-Reward?
Yahoo - 2026-09-27

Gilead vs. Abbott: Which Dividend Healthcare Stock Offers the Better Risk-Reward? 🔗

Gilead Sciences, Inc. (NASDAQ:GILD) and Abbott Laboratories (NYSE:ABT) both return cash to shareholders through dividends, but the businesses supporti...

Best Dividend Kings: September 2026
SeekingAlpha - 2026-09-26

Best Dividend Kings: September 2026 🔗

Dividend Kings are underperforming SPY in September, with a -4.22% average return versus SPY's marginal gain.

NVST vs. ABT: Which Stock Is the Better Value Option?
Yahoo - 2026-09-25

NVST vs. ABT: Which Stock Is the Better Value Option? 🔗

NVST vs. ABT: Which Stock Is the Better Value Option?

How To Build A $75,000 Dividend Portfolio With SCHD And 5 High-Yield Picks
SeekingAlpha - 2026-09-25

How To Build A $75,000 Dividend Portfolio With SCHD And 5 High-Yield Picks 🔗

Build a $75K dividend portfolio anchored by SCHD, enhanced with JEPI, VNG, and 8 quality stocks to boost yield, growth, and diversification—read ...

Abbott (ABT) Registers a Bigger Fall Than the Market: Important Facts to Note
Yahoo - 2026-09-24

Abbott (ABT) Registers a Bigger Fall Than the Market: Important Facts to Note 🔗

Abbott (ABT) concluded the recent trading session at $101.07, signifying a -2.34% move from its prior day's close.

Abbott Laboratories (ABT) is Facing Segment Competition and Sluggish Nutrition Recovery
Yahoo - 2026-09-24

Abbott Laboratories (ABT) is Facing Segment Competition and Sluggish Nutrition Recovery 🔗

Tributary Capital Management released its second-quarter 2026 investor letter for “Multi Cap Core Equity Strategy”. You can download a copy of the...

TDM Reagent Kit Market Forecasts Growth from $2.87B (2026) to $6.96B by 2032, Profiling Abbott, Roche, Danaher, Siemens Healthineers & Thermo Fisher
Yahoo - 2026-09-24

TDM Reagent Kit Market Forecasts Growth from $2.87B (2026) to $6.96B by 2032, Profiling Abbott, Roche, Danaher, Siemens Healthineers & Thermo Fisher 🔗

Opportunities center on automated, standardized TDM kits integrated with AI dosing tools for antimicrobial stewardship, transplant care and precision ...

Show more
SeekingAlpha - 2026-08-24

Best Dividend Kings: August 2026 🔗

SeekingAlpha - 2026-08-21

SCHD: We Were Horribly Wrong 🔗

SeekingAlpha - 2026-07-26

Best Dividend Kings: July 2026 🔗